These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2432618

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase.
    Jaschonek K, Faul C, Schmidt H, Renn W.
    Eur J Pharmacol; 1988 Mar 01; 147(2):187-96. PubMed ID: 2452749
    [Abstract] [Full Text] [Related]

  • 3. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA, Lawrence RA, Jones RL, Wilson NH, Collier A.
    Br J Pharmacol; 1989 Jul 01; 97(3):657-68. PubMed ID: 2474350
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
    Armstrong RA, Jones RL, MacDermot J, Wilson NH.
    Br J Pharmacol; 1986 Mar 01; 87(3):543-51. PubMed ID: 3026540
    [Abstract] [Full Text] [Related]

  • 6. Effect of heparin on platelet aggregation inhibited by PGI2, trifluoperazine and verapamil.
    Weber DR, Nichols WK, Mohammad SF.
    Thromb Res; 1986 May 15; 42(4):477-87. PubMed ID: 3012821
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of PGI2 on platelet aggregation and adenylate cyclase activity in human type IIa hypercholesterolemia.
    Colli S, Lombroso M, Maderna P, Tremoli E, Nicosia S.
    Biochem Pharmacol; 1983 Jul 01; 32(13):1989-93. PubMed ID: 6347202
    [Abstract] [Full Text] [Related]

  • 9. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA, Kappa JR, Sinha AK, Cottrell ED, Reiser HJ, Addonizio VP.
    J Lab Clin Med; 1987 Feb 01; 109(2):184-90. PubMed ID: 2433373
    [Abstract] [Full Text] [Related]

  • 10. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M, Nicosia S, Paoletti R, Whittle BJ, Moncada S, Vane JR.
    Prostaglandins; 1984 Feb 01; 27(2):321-33. PubMed ID: 6326201
    [Abstract] [Full Text] [Related]

  • 11. Effects of TRK-100, a stable prostacyclin analogue, on regulation of cyclic AMP metabolism in platelets.
    Nogimori K, Kajikawa N, Nishio S, Yajima M.
    Prostaglandins; 1989 Feb 01; 37(2):205-12. PubMed ID: 2543034
    [Abstract] [Full Text] [Related]

  • 12. Platelet prostacyclin binding in coronary artery disease.
    Jaschonek K, Karsch KR, Weisenberger H, Tidow S, Faul C, Renn W.
    J Am Coll Cardiol; 1986 Aug 01; 8(2):259-66. PubMed ID: 3016061
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects.
    Shepherd GL, Lewis PJ, Blair IA, de Mey C, MacDermot J.
    Br J Clin Pharmacol; 1983 Jan 01; 15(1):77-81. PubMed ID: 6342639
    [Abstract] [Full Text] [Related]

  • 15. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets.
    Fortini A, Modesti PA, Abbate R, Gensini GF, Neri Serneri GG.
    Thromb Res; 1985 Nov 01; 40(3):319-28. PubMed ID: 3001968
    [Abstract] [Full Text] [Related]

  • 16. Prostacyclin-lipoprotein interactions. Studies on human platelet aggregation and adenylate cyclase.
    Colli S, Maderna P, Tremoli E, Baraldi A, Rovati GE, Gianfranceschi G, Nicosia S.
    Biochem Pharmacol; 1985 Jul 15; 34(14):2451-7. PubMed ID: 3893439
    [Abstract] [Full Text] [Related]

  • 17. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V, Stemerman M, Schafer A, Adelman B, Smith M, Fuhro R, Salzman E.
    J Lab Clin Med; 1985 Nov 15; 106(5):551-61. PubMed ID: 2997353
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ, Davidson MM, Desjardins JV.
    Biochem J; 1978 Oct 15; 176(1):83-95. PubMed ID: 215136
    [Abstract] [Full Text] [Related]

  • 19. Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.
    Fujitani B, Wakitani K.
    Jpn J Pharmacol; 1990 May 15; 53(1):25-33. PubMed ID: 2161965
    [Abstract] [Full Text] [Related]

  • 20. Platelet prostacyclin binding in smokers.
    Jaschonek K, Weisenberger H, Tidow S, Daiss W, Renn W, Ostendorf P.
    J Lab Clin Med; 1986 Aug 15; 108(2):88-95. PubMed ID: 3016128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.